您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (6): 30-37.doi: 10.6040/j.issn.1671-7554.0.2024.0261

• 基础医学 • 上一篇    

羊角棉总生物碱增强氟尿嘧啶对结直肠癌化疗敏感性

王潇1,孔文茹1,崔伟亮2,王姝麒1   

  • 发布日期:2024-07-15
  • 通讯作者: 崔伟亮. E-mail:xinyao2002@126.com王姝麒. E-mail:wangsq@sdu.edu.cn
  • 基金资助:
    山东省重点研发计划(重大科技创新工程)项目(2021CXGC010511);国家重点研发计划-中医药现代化专项(2023YFC3504102);山东省自然科学基金(ZR2022MH224);国家药品监管科学体系建设重点项目(RS2024Z006)

Alstonia mairei total alkaloids enhance the sensitivity of colorectal cancer to 5-fluorouracil chemotherapy

WANG Xiao1, KONG Wenru1, CUI Weiliang2, WANG Shuqi1   

  1. 1. School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China;
    2. Shandong Institute for Food and Drug Control, Jinan 250101, Shandong, China
  • Published:2024-07-15

摘要: 目的 观察羊角棉总生物碱在结直肠癌治疗中对氟尿嘧啶(5-fluorouracil, 5-FU)的增敏作用,探讨其对5-FU药代动力学的影响。 方法 CCK-8法评价羊角棉总生物碱与5-FU联用对HCT15人结直肠腺癌细胞和CT26.WT小鼠结肠癌细胞杀伤能力;构建小鼠皮下瘤模型,观察5-FU和羊角棉总生物碱单用或联用时对肿瘤生长的影响;LC-MS/MS法检测5-FU及其代谢物二氢氟尿嘧啶(dihydrofluorouracil, FUH2)和氟脱氧尿苷(fluorodeoxyuridine, FUrd)在大鼠体内的药代动力学参数。 结果 羊角棉总生物碱对HCT15和CT26.WT细胞毒性的IC50值分别为31.98 μg/mL和23.71 μg/mL;低剂量(100 mg/kg)和高剂量(200 mg/kg)羊角棉总生物碱联用5-FU对荷瘤小鼠的抑瘤率从50.91%分别增长至58.56%和62.16%;5-FU联用羊角棉总生物碱后,T1/2显著延长,其代谢产物FUrd血药浓度显著下降。 结论 羊角棉总生物碱对结直肠癌细胞有一定的细胞毒性,与5-FU联用可显著增强其抗结直肠癌活性;羊角棉总生物碱可能通过降低二氢尿嘧啶脱氢酶浓度延缓5-FU分解代谢并调节其合成代谢途径,从而加强其生物学活性。

关键词: 羊角棉, 结直肠癌, 生物碱, 氟尿嘧啶, 细胞毒

Abstract: Objective To observe the sensitizing effect of Alstonia mairei total alkaloids on 5-fluorouracil(5-FU)in the treatment of colorectal cancer, and to explore the influence on the pharmacokinetics of 5-FU. Methods The cytotoxicity of Alstonia mairei total alkaloids combined with 5-FU on HCT15 human colorectal adenocarcinoma cells and CT26.WT mouse colon cancer cells was evaluated by CCK-8 kit. A mouse subcutaneous tumor model was established to observe the effects of 5-FU and Alstonia mairei total alkaloids on tumor growth when used alone or in combination. The pharmacokinetic parameters of 5-FU and its metabolites dihydrofluorouracil(FUH2)and fluorodeoxyuridine(FUrd)in rats were determined by LC-MS/MS. Results The IC50 values of Alstonia mairei total alkaloids on HCT15 and CT26.WT cells were 31.98 μg /mL and 23.71 μg /mL, respectively. The tumor inhibition rate of low dose(100 mg/kg)and high dose(200 mg/kg)Alstonia mairei total alkaloids combined with 5-FU in tumor-bearing mice increased from 50.91% to 58.56% and 62.16%, respectively. The T1/2 of 5-FU combined with Alstonia mairei total alkaloids was significantly prolonged, and the plasma concentration of FUrd was significantly decreased. Conclusion The Alstonia mairei total alkaloids have certain cytotoxicity against colorectal cancer cells, and its anti-colorectal cancer activity can be significantly enhanced in combination with 5-FU. Alstonia mairei total alkaloids may enhance the biological activity of 5-FU by reducing the concentration of DPD to delay the catabolism of 5-FU and regulate its anabolic pathway.

Key words: Alstonia mairei, Colorectal cancer, Alkaloids, 5-Fluorouracil, Cytotoxicity

中图分类号: 

  • R574
[1] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
[2] Dekker E, Tanis PJ, Vleugels JLA, et al. Colorectal cancer[J]. Lancet, 2019, 394(10207): 1467-1480.
[3] Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J]. Gut, 2017, 66(4): 683-691.
[4] Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974-2013[J]. J Natl Cancer Inst, 2017, 109(8): djw322. doi:10.1093/jnci/djw322.
[5] Bailey CE, Hu CY, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010[J]. JAMA Surg, 2015, 150(1): 17-22.
[6] Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society[J]. CA Cancer J Clin, 2018, 68(4): 250-281.
[7] Kasi PM, Shahjehan F, Cochuyt JJ, et al. Rising proportion of young individuals with rectal and colon cancer[J]. Clin Colorectal Cancer, 2019, 18(1): e87-e95.
[8] Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2018, 29(Suppl 4): iv263. doi:10.1093/annonc/mdy161.
[9] Vodenkova S, Buchler T, Cervena K, et al. 5-Fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future[J]. Pharmacol Ther, 2020, 206: 107447. doi:10.1016/j.pharmthera.2019.107447.
[10] Veenstra CM, Krauss JC. Emerging systemic therapies for colorectal cancer[J]. Clin Colon Rectal Surg, 2018, 31(3): 179-191.
[11] Blondy S, David V, Verdier M, et al. 5-Fluorouracil resistance mechanisms in colorectal cancer: from classical pathways to promising processes[J]. Cancer Sci, 2020, 111(9): 3142-3154.
[12] Heidelberger C, Chaudhuri NK, Danneberg P, et al. Fluorinated pyrimidines, a new class of tumour-inhibitory compounds[J]. Nature, 1957, 179(4561): 663-666.
[13] Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20, 898 patients on 18 randomized trials[J]. J Clin Oncol, 2009, 27(6): 872-877.
[14] Latchman J, Guastella A, Tofthagen C. 5-Fluorouracil toxicity and dihydropyrimidine dehydrogenase enzyme: implications for practice[J]. Clin J Oncol Nurs, 2014, 18(5): 581-585.
[15] Zhang LL, Xing XL, Meng FL, et al. Oral fluoropyrimidine versus intravenous 5-fluorouracil for the treatment of advanced gastric and colorectal cancer: Meta-analysis[J]. J Gastroenterol Hepatol, 2018, 33(1): 209-225.
[16] Ahn DH, Wu C, Wei L, et al. The efficacy of adjuvant chemotherapy in patients with stage II/III resected rectal cancer treated with neoadjuvant chemoradiation therapy[J]. Am J Clin Oncol, 2017, 40(6): 531-534.
[17] Lee GY, Lee JS, Son CG, et al. Combating drug resistance in colorectal cancer using herbal medicines[J]. Chin J Integr Med, 2021, 27(7): 551-560.
[18] Li YQ, Cai J, Cheng JX, et al. Alstomairines D-G: new monoterpenoid indole alkaloids with cytotoxic activity from Alstonia mairei[J]. J Mol Struct, 2022, 1253: 132277. doi:10.1016/j.molstruc.2021.132277.
[19] Yan TL, Han DX, Hu J, et al. Monoterpenoid indole alkaloids from Alstonia mairei and their cytotoxicity[J]. J Asian Nat Prod Res, 2017, 19(6): 550-556.
[20] Cai XH, Zeng CX, Feng T, et al. Monoterpenoid indole alkaloids from Alstonia mairei[J]. Helv Chim Acta, 2010, 93(10): 2037-2044.
[21] Sobrero A, Aschele C, Guglielmi A, et al. Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implications[J]. J Chemother, 1990, 2(Suppl 1): 12-16.
[22] Johnston PG, Kaye S. Capecitabine: a novel agent for the treatment of solid tumors[J]. Anticancer Drugs, 2001, 12(8): 639-646.
[23] Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: mechanisms of action and clinical strategies[J]. Nat Rev Cancer, 2003, 3(5): 330-338.
[24] Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil[J]. Clin Pharmacokinet, 1989, 16(4): 215-237.
[1] 魏闫若雪,李梓绮,刘春铖,刘晓晗,赵然,刘玉昆. 结直肠癌中SP1的瘤内异质性表达及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(5): 89-94.
[2] 刘春铖,刘晓晗,魏闫若雪,李梓绮,刘玉昆,赵然. 结直肠癌中含溴结构域蛋白9的亚细胞定位模式及其临床意义[J]. 山东大学学报 (医学版), 2024, 62(4): 24-30.
[3] 董雅琪,王新慧,赵颖慧,王传新. 血清外泌体LINC02163作为结直肠癌远处转移标志物的临床价值[J]. 山东大学学报 (医学版), 2023, 61(9): 19-28.
[4] 孙富云,王维鹏,张会会,耿艳,安小霞,李双双,张彬彬. 结直肠癌术后患者人格特质与抑郁、焦虑症状的关联性[J]. 山东大学学报 (医学版), 2021, 59(7): 91-96.
[5] 杜甜甜,李娟,赵颖慧,段伟丽,王景,王允山,杜鲁涛,王传新. 长链非编码RNA LINC02474在结直肠癌中的表达特征及对细胞增殖的影响[J]. 山东大学学报 (医学版), 2021, 59(10): 59-69.
[6] 李宁,李娟,谢艳,李培龙,王允山,杜鲁涛,王传新. 长链非编码RNA AL109955.1在80例结直肠癌组织中的表达及对细胞增殖与迁移侵袭的影响[J]. 山东大学学报 (医学版), 2020, 1(7): 38-46.
[7] 王天霄,李静,李海林. 网络问卷结直肠早癌筛查效果的初步评估[J]. 山东大学学报 (医学版), 2020, 58(4): 90-94.
[8] 李乐平,崔怀平,商亮. 加速康复外科在胃肠外科手术中的应用[J]. 山东大学学报 (医学版), 2019, 57(9): 5-11.
[9] 吴成威,孙博实,周军德,蒋天明,迟强. 术前口服多糖溶液对结直肠癌患者术后胰岛素抵抗的关联性研究[J]. 山东大学学报 (医学版), 2019, 57(9): 48-53.
[10] 郭艳,张哲莹,王云溪,魏小娟. 人源性长寿保障基因2在结直肠癌组织中的表达及其临床意义[J]. 山东大学学报 (医学版), 2019, 57(7): 67-71.
[11] 耿旭,张璐,李明,卢志明. 多种肿瘤自身抗体对结直肠癌诊断的应用价值[J]. 山东大学学报 (医学版), 2019, 57(4): 65-71.
[12] 马冉冉,韩琛,王朝霞,王兆朋,高誉欣,周淑萍,张月英,李小兵,刘恒铫,王恒孝. 人参总皂苷调控NK细胞活性促进5-氟尿嘧啶抗肿瘤的作用[J]. 山东大学学报 (医学版), 2018, 56(4): 43-50.
[13] 朱宇,王宏洁,韩彬彬,冯莎娜,张春,李学祥,韩晓红,崔巍. 人异常凝血酶原(PIVKA-II)在监测结直肠癌肝转移中的应用[J]. 山东大学学报 (医学版), 2018, 56(10): 58-63.
[14] 姚铁柱,马景涛,郭丽敏. 尼可地尔治疗5-氟尿嘧啶诱发冠脉痉挛1例报道[J]. 山东大学学报(医学版), 2016, 54(3): 95-96.
[15] 刘慧敏, 刘邓, 李晓宇, 邹淑奉, 姜黎民, 李玉环. 半边莲生物碱对肺动脉高压大鼠ET-1信号通路的影响[J]. 山东大学学报(医学版), 2015, 53(8): 1-4.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!